ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,560 | -23.1% | 7,393 | -0.6% | 0.00% | – |
| Q2 2023 | $342,930 | +42.8% | 7,434 | +24.1% | 0.00% | – |
| Q1 2023 | $240,119 | -11.6% | 5,988 | +2.2% | 0.00% | – |
| Q4 2022 | $271,540 | -15.9% | 5,861 | +8.3% | 0.00% | – |
| Q2 2022 | $323,000 | -17.8% | 5,412 | +0.1% | 0.00% | – |
| Q1 2022 | $393,000 | +58.5% | 5,409 | +83.2% | 0.00% | – |
| Q4 2021 | $248,000 | +13.8% | 2,952 | +22.2% | 0.00% | – |
| Q3 2021 | $218,000 | -4.4% | 2,415 | +0.9% | 0.00% | – |
| Q2 2021 | $228,000 | -25.2% | 2,393 | -10.8% | 0.00% | – |
| Q1 2021 | $305,000 | -17.3% | 2,682 | +0.6% | 0.00% | – |
| Q4 2020 | $369,000 | – | 2,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |